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 Breast cancer is malignancy that becomes significant health problem in the 
world. According to WHO data in 2018, there were 2.1 million cases of breast 
cancer with mortality rate reaching 627,000. Current breast cancer treatments 
are surgery, radiation therapy, hormonal therapy and chemotherapy. However, 
these treatments have side effects such as neuropathy, fatigue after undergoing 
chemotherapy, and alopecia. Natural ingredients are the choice to overcome 
these weaknesses, one of which is the utilization of piperine in Balinese long 
pepper (Piper retrofractum Vahl). Piperine can increase the bioavailability of 
many drugs by increasing absorption from the intestine, suppressing the 
metabolism of drugs in lung and liver tissue by inhibiting CYP3A4 and P84 
glycoprotein P84. Piperine is easily absorbed in the intestine and excreted 
through urine and feces, causing minimal toxic effects. Piperine in Balinese long 
pepper is able to reduce breast cancer cell proliferation by 40%. Piperine can also 
inhibit epidermal growth factor (EGF) by inducing decreased expression of MMP-
9 and MMP-13. Piperine will work through inhibition of NF-κB and PKCα 
phosphorylation and AP-1 activation by interfering extracellular signal-regulated 
kinase (ERK) signaling pathway (ERK) 1/2, p38 MAPK, and Akt which results in 
inhibition of migration and metastasis of breast cancer cells. 
 
Introduction 
Breast cancer is malignancy that is a major health problem in the world. According to  World Health 
Organization (WHO) statistics in 2018, there are 2.1 million diagnosed breast cancer events and 627,000 
deaths with 90% of cases found at advanced stage or metastasis(1). Data from the International Agency for 
Research on Cancer (IARC) in 2018 shows that breast cancer is the most common diagnosed cancer in 
women, reaching 24.2% or about 1 in 4 new cases of cancer diagnosed in women worldwide (2). The 
incidence of breast cancer in Indonesia is recorded at 42.1 per 100,000 population in 2018 with average 
mortality rate of 17 per 100,000 population (3). Based on data from Bali Provincial Health Office in 2011, 
75% of breast cancer patients were diagnosed at advanced stage and 25% at early stage (4). 
Data from Association of Indonesian Surgical Oncologists, patients with stage 0 breast cancer have 98% 
life expectancy for 10 years, stage II have 60-70% within a period of 5 years, stage III have 30-50% life 
expectancy and stage IV have 15% life expectancy (5). Treatments of breast cancer that are used today 
including surgery (mastectomy or lumpectomy), radiation therapy, hormonal therapy and chemotherapy, 
which can be adjusted to the stage and type of breast cancer (6). However, treatments of breast cancer have 
several weaknesses such as chemotherapy that cause many side effects like neuropathy, cardiomyopathy, 
leukemia, and excessive fatigue after undergoing chemotherapy, and alopecia that is felt by more than 50% 
of breast cancer patients. 
Metastatic condition is characterized by the spread of cancer cells from primary tumors to other 
normal body tissues initiated by cell release from primary tumors, invasion and migration, intravasation, 
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transport through blood vessels or lymph, extravasation and formation of secondary tumors. Generally, 
breast cancer will metastasize to the bones, skin, liver, lung and adrenal. Increased cancer cell metastasis to 
other parts of the body will cause higher morbidity and mortality rates (6).This condition causes the need 
for alternative therapies with minimum side effects for breast cancer. 
Natural ingredients are often thought to be the choice to overcome current weaknesses of cancer 
treatment. One of the potential natural ingredients for anti-cancer therapy is Piper retrofractum Vahl. Piper 
retrofractum Vahl has many local names such as, cabai jawa (Java), cabi sola (Madura), cabia (Sulawesi), lada 
panjang (Malay) and tabia bun (Bali). Balinese long pepper is also called tabia bun is a part of Ayurveda 
which is a science that studies medicinal plants to improve human health following these phases, which are, 
cleansing, cell rejuvenation and disease management (7). In Indonesia, Balinese long pepper plant is 
designated as traditional medicinal plant by the Indonesian Food and Drug Supervisory Agency with 
superior compounds, namely piperine and flavonoid, as well as other ingredients such as cavisin, essential 
oils, and saponins. The pharmacological properties of Piper retrofractum Vahl including antioxidant, 
antimalarial, antibacterial, central nervous depressant activity, antidiabetic and even anticancer (7). The 
purpose of this article review is to determine the effectiveness of tabia bun (Piper Retrofractum V) as an 
anti-proliferation and anti-metastatic agent in breast cancer. 
 
Method 
Writing a scientific paper, this literature review using literature study method. The literature sources 
consist of relevant journals from search engines such as www.pubmed.com, proquest.com, and 
scholar.google.com. Using the keyword: Anti-metastatic, Anti-proliperative, Breast Cancer, Piperine, Piper 
retrofractum. The inclusion criteria are all breast cancer samples, and references should not exceed the last 
ten years unless there is no new study related to the contents of the reference. Forty-five journals have been 
reviewed, 21 of them were found suitable as a reference for this literature. 
 
Result 
General Overview of Breast Cancer 
Breast cancer can occur due to interaction between environmental and genetic factors. The 
pathogenesis begins with invasive cancer cells that arise due to molecular mutations and cellular signaling 
pathways. The PI3K / AKT pathway and the RAS / MEK / ERK pathway is able to protect normal cells from 
cell death. When mutations occur in genes that encode these pathways, cells become unable to carry out 
apoptosis when they are no longer needed, thus leading to cancer development. Some mutations associated 
with breast cancer are p53, BRCA1 and BRCA2. Mutation conditions will cause uncontrolled cell 
proliferation, lack of attachment and metastasis to distant organs (8). According to The Cancer Genome 
Atlas Network (TCGA), there are four subtypes of breast cancer with genetic deviations namely Luminal A, 
Luminal B, Basal- Like, and HER-2 Positive (9). 
Luminal A breast cancer is the most common subtype. This type has characteristics which are positive 
estrogen receptor (ER), and/or positive progesterone receptor (PR), and negative Human endothelial 
growth Factor Receptor 2 (HER2). This subtype is usually found at low stage breast cancer with low 
aggressiveness level, thus it has good prognosis. Meanwhile, luminal B breast cancer has characteristic like 
positive ryaotu estrogen receptor (ER), and/or positive progesterone receptor (PR), and positive Human 
endothelial growth Factor Receptor 2 (HER2). However, positive ER and negative PR are found more often. 
The prognosis of luminal B breast cancer is worse than Luminal A (10,11). Basal-Like breast cancer is an 
aggressive subtype characterized by Triple Negative (negative ER, negative PR, and negative HER2), 
cytokeratin 5/6, and/or positive EGFR (12). Positive HER2 type (HER2 +) is a subtype that is rarely found 
in breast cancer patients but is an aggressive subtype and is often found at advanced stage breast cancer. 
Estrogen and progesterone receptors in this subtype are negative (10,11). 
 
Overview of Piper retrofractum Vahl Fruit 
Piper retrofractum Vahl has many local names like cabai jawa (Java), cabi sola (Madura), cabia (Sulawesi), 
lada panjang (Malay) and tabia bun (Bali). In addition to its abundant presence in Bali, Balinese long 
pepper (tabia bun) is also widely grown throughout Indonesia because it is highly adaptable. Some 
bioactive compounds such as piperine alkaloid, cavisin, piperidine, isobutane-trans-2-trans4-dienamide; 
saponins, polyphenols, essential oils, palmitic acid, tetrahydropyperic acid, 1 undesilenyl-3,4 
methylenedioxybenzene, sesamin, and piplartine are present in Balinese long pepper fruit. The percentage 
of piperine content in this fruit is about 2% and essential oil is about 1%. Balinese long pepper fruit’s 
essential oils consists of three main components, namely β-caryophyllene (17%), pentadecane (17.8%) 
and β-bisabolene (11.2%) (13,14). 
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Anti-Proliferative and Anti-Metastatic Agents of Piper retrofractum Vahl in Breast Cancer 
 
 
 
Figure 1. (A) Inhibition of growth by piperine in 4T1 cells; (B) The IC50 values of piperine on 4T1 cells 
(15). 
 
 
Figure 2. (A) The apoptotic cell death was quantified as Annexin V; (B) Western blot analysis of caspase 3, 
Bcl-2 and Bax in 4T1 cells treated with or without piperine (15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Down-regulated the expression of MMP-9 and MMP-13. The mRNA expression of MMP-9 and 13 
in 4T1 cells treated by piperine at different concentrations (0, 70, and 140 μmol/L) for 24 h was detected 
by real-time PCR and normalized to the expression of GAPDH in each sample (15). 
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Figure 4. Piperine inhibited the metastasis of 4T1 tumors in vivo. 4T1 cells were implanted 
subcutaneously into the female BALB/c mice. After three days of implantation, piperine (0 and 
5 mg/kg) was dissolved in 0.2% DMSO and intratumorally injected every three days for three 
times(15). 
. 
 
  
 
Figure 5. Piperine inhibited 4T1 cell migration in vitro (15). 
 
 
 
Discusion  
Until now, piperine is the first and the most effective bio enhancer. Piperine can enhance the 
bioavailability of many drugs by increasing absorption from intestine, suppressing drugs metabolism in 
lung and liver tissue by inhibiting CYP3A4 and P84 glycoprotein P84(16). According to pharmacokinetic 
study in humans, there is no accumulation of piperine after daily oral dose of 20 mg piperine for 7 days 
which is observed in blood serum. About 97% of piperine will be absorbed in the intestine while the 
remaining 3% will be excreted in urine and feces (17). There are no studies showing piperine toxicity in 
humans in the included literature, but in vivo studies show that doses above 1.12 mg/kg is able to cause 
central nervous system depression and reproductive toxicity. The in vitro anti-proliferative effect of 
piperine was tested on 4T1 cells at dose of 140 μmol / L and 280 μmol / L for 24 hours (Figure 1A). The 
results showed reduction in cell viability from 100% to 78% and 48% compared to the control group. 
Piperine administration for 48 hours at dose of 140 μmol / L and 280 μmol / L, was able to cause decreased 
in cell viability from 100% to 33% and 18% (Figure 1A). IC50 values for piperine were 105 ± 1.08 μmol / L 
for 48 hours, and 78.52 ± 1.06 μmol / L for 72 hours treatment (Figure 1B), which indicated that inhibition 
of breast cancer cell growth was dose dependent (18). 
The piperine content in 100 ug / mL Piper retrofractum Vahl extract successfully acts as an anti-
proliferative as much as 40% in breast cancer cells.[18] Besides piperine, Piper retrofractum Vahl extract also 
contains 6.56 mg QE / g flavonoid compounds which can increase p53 expression and have 95.89% 
inhibitory effect in MCF-7 cells with 250 μg / mL concentration (19). The anti-metastatic effect of piperine 
can be tested using different concentrations, starting from 0, 140, and 280 μmol / L for 24 hours, analysed 
by Annexin V-FITC / PI double-labelled flow cytometry. Administration of piperine of 140 and 280 μmol / L 
for 24 hours, increased apoptosis by 24.2% and 23.6% compared to control group (Figure 2A). Studies by 
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Lai et al. show that, the effect of piperine on the expression levels of the Bcl-2 family, the pro-apoptotic Bax 
and the anti-apoptotic Bcl-2, which regulates mitochondrial apoptosis (Figure 2B). When Bax is 
overexpressed in cells, apoptotic death in response to death signals is accelerated, while Bcl-2 is 
overexpressed, it is heterodimerized with Bax and the cell death is repressed. Following the exposure to 
piperine, it is found that there is no change of Bax and Bcl-2 at protein levels in the 4T1 cells, indicating that 
the apoptosis induced by piperine is not dependent of the Bcl-2 pathway. In addition, the anti-metastatic 
effect of piperine is also related to Matrix Metalloproteinases (MMPs). This protein has the capacity to 
reduce the extracellular matrix (ECM) component and change its biological function. It is well-known that 
the process of tumor cell metastasis requires the degradation of ECM molecules in the basement membrane, 
which is the largest barrier between cancer cells and bloodstream. The essential proteases that are involved 
in ECM degradation contain MMPs (15). 
The content of piperine in Piper retrofractum Vahl can affect the expression of matrix 
metalloproteinases (MMPs) such as MMP-1, MMP-2, MMP-3 and MMP-9, MMP-13 (20). MMP-9 is one of the 
largest MMP types in all MMP family of proteinase enzymes which has 92 kDa molecular weight. MMP-9 
has the ability to increase type IV collagen degradation, which is the main component of the basal 
membrane which is also involved in cancer cells metastasic process. Research in 2014 shows that increase 
in MMP-9 expression is directly proportional to the increase in tumor histology grade and metastasis (21). 
Piperine can significantly reduce MMP-9 and MMP-13 expressions (Figure 3). It has been reported that 
piperine can suppress MMP-9 expression in tumor cells through inhibition of PKCα and ERK 
phosphorylation and reduction of NF-κB and AP-111 activation. MMP-13 has been shown to be expressed 
in more invasive breast carcinoma cells, and some evidence indicates that increased expression of MMP-13 
derived independently from tumors has poor prognosis. It is thought that the inhibitory effect of piperine 
on oxygenase, p450 isoenzymes and cycloxygenase-1 expression can contribute to antimetastatic quality 
(15). 
4T1 cells can also metastasize to various organs, such as the lungs. Lai et al. showed that less 
metastasis in the lungs of mice that had been given piperine 5 mg/kg compared with control mice (Figure 
4). The results indicated that piperine not only suppressed the growth of local primary tumors but also 
effectively controlled the occurrence of spontaneous metastasis. Besides, piperine is also be able to inhibit 
the ability of in vitro 4T1 cells migrations which can be proven by wound healing tests. Piperine was 
administered to cell at concentrations of 0,70, and 140 μmol / L, and the results showed that piperine 
inhibited 4T1 cell migration in  dose-dependent manner (Figure 5) (15). Piperine is a compound that can 
inhibit epidermal growth factor (EGF) by inducing reduction on MMP expression and working through 
inhibition of NF-κB and activation of AP-1 by interfering extracellular signal-regulated kinase (ERK) 
signaling pathway 1/2, p38 MAPK, and Akt which results in inhibition of cell migration (20). 
 
Conclusion and suggestion 
Balinese long pepper (Piper retrofractum Vahl) contains piperine, flavonoids and essential oils which 
have many properties such as, antioxidants, antimalarial, antibacterial, central nervous depressant activity, 
antidiabetic and even anticancer. Piperine can increase the bioavailability of many drugs by increasing 
absorption from the intestine, suppressing the metabolism of drugs in lung and liver tissue by inhibiting 
CYP3A4 and P84 glycoprotein P84. Piperine acts as bioenhancer that is widely used today since it is easily 
absorbed in the intestine, and can be excreted through urine and feces, and causing minimal toxic effects. 
Piperine is able to reduce 40% of breast cancer cell proliferation. Flavonoid content in Piper retrofractum 
Vahl can also increase the expression of p53 and has inhibitory effect towards MCF-7 breast cancer cells 
growth. Piperine can inhibit epidermal growth factor (EGF) by inducing reduction in MMP-9 and MMP-13 
expression. Piperine will work through inhibition of NF-κB and PKCα phosphorylation and AP-1 activation 
by interfering extracellular signal-regulated kinase (ERK) signalling pathway 1/2, p38 MAPK, and Akt thus, 
it has the ability to inhibit breast cancer cells migration and metastasis. Further research is needed to 
determine the effectiveness of piperin in Piper retrofractum at the in vivo level research and clinical trials. It 
is hoped that the piperin extract in the Piper retrofractum can be used as a therapy for the treatment of 
breast cancer in the future. 
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